CJC-1295 Peptide Therapy at Drip Wellness IV

What Is CJC-1295?

CJC-1295 is a modified synthetic analog of growth hormone-releasing hormone (GHRH), designed with a longer biological half-life to allow for less frequent dosing while maintaining consistent support for natural growth hormone release from the pituitary gland. At Drip Wellness IV, CJC-1295 is available as part of individualized peptide programs developed by our licensed medical providers. CJC-1295 is often utilized in combination with GHRP peptides as part of a broader growth hormone optimization protocol. All programs are customized based on client health assessments and wellness objectives. CJC-1295 is administered under proper medical supervision and in full compliance with applicable regulations. Content on this page is intended for educational and informational purposes only and does not constitute medical advice or a treatment recommendation.